Back to Search
Start Over
Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
- Source :
-
Journal of bioenergetics and biomembranes [J Bioenerg Biomembr] 2022 Apr; Vol. 54 (2), pp. 109-117. Date of Electronic Publication: 2022 Mar 08. - Publication Year :
- 2022
-
Abstract
- Lysophosphatidic acid (LPA) signaling via LPA receptors (LPA <subscript>1</subscript> to LPA <subscript>6</subscript> ) exhibits a variety of malignant properties in cancer cells. Intracellular ATP depletion leads to the development of necrosis and apoptosis. The present study aimed to evaluate the effects of LPA receptor-mediated signaling on the regulation of cancer cell functions associated with ATP reduction. Long-term ethidium bromide (EtBr) treated (MG63-EtBr) cells were established from osteosarcoma MG-63 cells. The intracellular ATP levels of MG63-EtBr cells were significantly lower than that of MG-63 cells. LPAR2, LPAR3, LPAR4 and LPAR6 gene expressions were elevated in MG63-EtBr cells. The cell motile and invasive activities of MG63-EtBr cells were markedly higher than those of MG-63 cells. The cell motile activity of MG-63 cells was increased by LPA <subscript>4</subscript> and LPA <subscript>6</subscript> knockdowns. In cell survival assay, cells were treated with cisplatin (CDDP) every 24 h for 3 days. The cell survival to CDDP of MG63-EtBr cells was lower than that of MG-63 cells. LPA <subscript>2</subscript> knockdown decreased the cell survival to CDDP of MG-63 cells. The cell survival to CDDP of MG-63 cells was inhibited by (2 S)-OMPT (LPA <subscript>3</subscript> agonist). Moreover, the cell survival to CDDP of MG-63 cells was enhanced by LPA <subscript>4</subscript> and LPA <subscript>6</subscript> knockdowns. These results indicate that LPA signaling via LPA receptors is involved in the regulation of cellular functions associated with ATP reduction in MG-63 cells treated with EtBr.<br /> (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Subjects :
- Adenosine Triphosphate pharmacology
Cell Movement
Ethidium pharmacology
Gene Expression Regulation, Neoplastic
Humans
Lysophospholipids metabolism
Receptors, Lysophosphatidic Acid genetics
Receptors, Lysophosphatidic Acid metabolism
Bone Neoplasms drug therapy
Bone Neoplasms genetics
Osteosarcoma drug therapy
Osteosarcoma genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1573-6881
- Volume :
- 54
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of bioenergetics and biomembranes
- Publication Type :
- Academic Journal
- Accession number :
- 35260987
- Full Text :
- https://doi.org/10.1007/s10863-022-09933-8